TODO
Gillings School Directory
Karine Dubé, DrPH
TODO

Karine Dubé, DrPH

Assistant Professor
Public Health Leadership Program
  • MacGavran-Greenberg 4108
  • CB 7469
  • Chapel Hill, NC 27599
  • USA
Karine Dubé, DrPH, MPhil (Oxon) is a socio-behavioral researcher and an experienced research program manager. Her current work focuses on integrating socio-behavioral research as part of actual HIV cure trials in the United States. Karine bridges biomedical, socio-behavioral sciences and ethics in infectious diseases research. She has close to 15 years of experience in infectious diseases-related work, including Ebola and HIV prevention and cure research. She has also worked in the areas of malaria control and treatment, HSV-2 prevention and treatment, sexual and reproductive health and family planning.
 
Karine previously served as a research program manager for the Collaboratory of AIDS Researchers for Eradication (CARE) at UNC-Chapel Hill. She also is the co-founder and co-leader of the CUREiculum (http://www.avac.org/cureiculum), a collaborative program aimed at making HIV cure science accessible to the community and the HIV research field.
 
Karine has extensive experience working in resource-limited settings and developing clinical research site capacity. She managed a pox-protein prime-boost HIV-1C vaccine cohort development program, two HIV-1C prospective incidence studies and a clinical research site capacity development effort in Maputo, Beira and Chókwè, Mozambique with the United States Military HIV Research Program, Walter Reed Army Institute of Research, Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. and FHI 360 (from 2008–2013). Karine also has served as a research and program analyst with amfAR, the Foundation for AIDS Research.
 
She currently serves as Associate Editor for BMC Public Health and Academic Editor for PLoS One.

Honors and Awards

Arthur B. Holzworth Endowed Scholarship in Health Leadership

2015, University of North Carolina at Chapel Hill

Representative Courses

Introduction to Global Public Health (SPHG 700) | Syllabus

Critical Issues in Global Health (PUBH 711) | Syllabus

Global Health Ethics (PUBH 712) | Syllabus

The AIDS Course- Online (PUBH 725) | Syllabus

Research Activities

- HIV
- Infectious Diseases
- Interdisciplinary Research


Key Publications

Ethical Considerations for HIV Cure-Related Research at the End of Life. Dubé K, Gianella S, Concha-Garcia S, Little SJ, Kaytes A, Taylor J, Mathur K, Javadi S, Nathan A, Patel H, Luter S, Philpott-Jones S, Brown B, Smith D. (2018). BMC Medical Ethics, 19(83).
View on ReachNC

Willingness to Participate in HIV Research at the End of Life (EOL). Katya Prakash, Sara Gianella , Karine Dubé, Jeff Taylor, GaYoung Lee, Davey M. Smith (2018). PLoS ONE, 13(7).
View on ReachNC

Use of "Eradication" in HIV Cure-Related Research: A Public Health Debate. Dubé K, Luter S, Lesnar B, Newton L, Galea J, Brown B, Gianella S.  (2018). BMC Public Health, 18(245).
View on ReachNC

Research on HIV Cure: Mapping the Ethics Landscape. Dubé K, Sylla L, Dee L, Taylor J, Evans D, Bruton CD, Gilbertson A, Gralinkski L, Brown B, Skinner A, Weiner BJ, Greene SB, Corneli A, Adimora AA, Tucker JD, Rennie S. (2017). PLoS Medicine, 14(12), e1002470.
View on ReachNC

Crucial but Understudied: Incentives in HIV Research. Brown B, Galea JT, Dubé K. (2017). Lancet HIV..
View on ReachNC

If We Build It, Will They Come? Perceptions of HIV Cure-Related Research by People Living with HIV in Four U.S. Cities – A Qualitative Focus Group Study. Sylla LN, Evans D, Taylor J, Gilbertson AL, Palm D, Auerbach JD, Dubé K. (2017). AIDS Research and Human Retroviruses.
View on ReachNC

Interrupting Antiretroviral Treatment in HIV Cure Research: Scientific and Ethical Considerations. Garner SA, Rennie S, Ananworanich J, Dubé K, Margolis DM, Sugarman J, Tressler R, Gilbertson A, Dawson L.  (2017). Journal of Virus Eradication, 3(2), 82-4.
View on ReachNC

Perceptions of Equipoise, Risk-Benefit Ratios, and “Otherwise Healthy Volunteers” in the Context of Early-Phase HIV Cure Research in the United States: A Qualitative Inquiry. Dubé K, Dee L, Evans D, Sylla L, Taylor J, Brown B, Miller V, Corneli A, Skinner A, Greene SB, Tucker JD, Rennie S.  (2017). Journal of Empirical Research on Human Research Ethics.
View on ReachNC

Reply to Commentary: “Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy.”. Dubé K, Sylla L, Dee L. (2017). Journal of Empirical Research on Human Research Ethics.
View on ReachNC

‘Well, It’s the Risk of the Unknown… Right?’: A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States. Dubé K, Taylor J, Sylla L, Evans D, Dee L, Burton A, Willenberg L, Rennie S, Skinner A, Tucker JD, Weiner BJ, Greene SB.  (2017). PLoS One, 12(1).
View on ReachNC

'We Need to Deploy Them Very Thoughtfully and Carefully’: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States – A Qualitative Inquiry. Dubé K, Evans D, Dee L, Sylla L, Taylor J, Skinner A, Weiner BJ, Greene SB, Rennie S, Tucker JD. (2017). AIDS Research and Human Retroviruses.
View on ReachNC

Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the U.S. Dubé K, Evans D, Sylla L, Taylor J, Weiner BJ, Skinner A, Thirumurthy H, Tucker JD, Rennie S, Greene SB. (2017). Journal of Virus Eradication, 3.
View on ReachNC

Towards a Multi-Disciplinary HIV Cure Research Agenda: Integrating the Social Science with Biomedical and Clinical Research. Grossman CI, Ross AL, Auerbach JD, Ananworanich J, Dubé K, Tucker JD, Noseda V, Possas C, Rausch D.  (2016). Trends in Microbiology, 24(1), 5-11.
View on ReachNC

How Does the Timing of Antiretroviral Therapy Initiation in Acute Infected Affect HIV Reservoir? Ananworanich J, Dubé K, Chomont N.  (2015). Current Opinion in HIV/AIDS, 10(1), 18-28.
View on ReachNC

Participation in HIV Cure Research: A Scoping Review of the Proxy Literature and Implications for Future Research. Dubé K, Ramirez C, Handibode J, Taylor J, Skinner A, Greene SB, Tucker JD.  (2015). The Journal of Virus Eradication, 1.
View on ReachNC

Framing Expectations in Early HIV Cure Research. Dubé K, Henderson GE, Margolis DM.  (2014). Trends in Microbiology – Science and Society, 22(10), 547-9.
View on ReachNC

HIV Incidence in a Cohort of Women at Higher Risk in Beira, Mozambique: Prospective Study 2009 – 2012. Dubé K, Zango A, Wijgert Jvd, Meque I, Ferro JJ, Cumbe F, Chen PL, Ma S, Jolles E, Fumo A, Robb ML, Feldblum PJ. (2014). PLoS One, 9(1).
View on ReachNC

Willingness to Participate in Future HIV Prevention Trials in Beira, Mozambique. Meque I, Dubé K, Bierhuizen L, Zango A, Veldhuijzen N, Cumbe F, Feldblum PJ, Wijgert Jvd. (2014). African Journal of AIDS Research, 13(4), 393-8.
View on ReachNC

Stigma and Ebola survivorship in Liberia: Results from a longitudinal cohort study. Overholt L, Wohl DA, Fischer II WA, Westreich D, Tozay S, Reeves E, Pewu K, Adjasso D, Hoover D, Merenbloom C, Johnson H, Williams G, Conneh T, Diggs J, Buller A, McMillian D, Hawks D, Dube K, Brown J (2018). PLOS One, 13(11).
View on ReachNC

Ebola Virus RNA Detection in Semen More than Two Years after Resolution of Acute Ebola Virus Infection. Fischer WA II, Brown J, Wohl DA, Loftis AJ, Tozay S, Reeves E, Pewu K, Gorvego G, Quellie S, Cunningham CK, Merenbloom C, Napravnik S, Dubé K, Adjasoo D, Jones E, Bonarwolo K, Hoover D. (2017). Open Forum Infectious Diseases.
View on ReachNC

Validation of the Cepheid GeneXpert for Detecting Ebola Virus in Semen. Loftis AJ, Quellie S, Chason K, Sumo E, Toukolon M, Otieno Y, Ellerbrok H, Hobbs MM, Hoover D, Dube K, Wohl DA, Fischer WA II.  (2017). Journal of Infectious Diseases.
View on ReachNC

Education

DrPH, Public Health, University of North Carolina at Chapel Hill, 2016

MPhil, Development Studies / International Health, Oxford University, 2005

BA, International Studies / Global Health (Minor in Business Administration), University of North Carolina at Chapel Hill, 2003

Recent News